Increased thyroid autoimmunity among women with multiple sclerosis in the postpartum setting

Multiple Sclerosis Journal

Volumn 19, Issue 13, 2013, Pages 1734-1742

  Jalkanen, A ^a   Saraste, M ^b   Gfeller, A ^a   Surcel, H M ^c   Airas, L ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Multiple sclerosis; postpartum thyroiditis; pregnancy; thyroid antibodies

Indexed keywords

BETA INTERFERON; GLATIRAMER; STEROID; THYROGLOBULIN; THYROID ANTIBODY; THYROID HORMONE;

ADULT; ADVERSE OUTCOME; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; DELIVERY; FATIGUE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MULTIPLE SCLEROSIS; PREGNANCY OUTCOME; PREVALENCE; PROCEDURES; PUERPERAL DEPRESSION; PUERPERIUM; RISK ASSESSMENT; THYROGLOBULIN BLOOD LEVEL; THYROID DISEASE;

MULTIPLE SCLEROSIS; POSTPARTUM THYROIDITIS; PREGNANCY; THYROID ANTIBODIES;

ADULT; ANTIBODIES; CASE-CONTROL STUDIES; DELIVERY, OBSTETRIC; DEPRESSION, POSTPARTUM; FATIGUE; FEMALE; HUMANS; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; POSTPARTUM THYROIDITIS; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; PROSPECTIVE STUDIES; RECURRENCE; RISK; STEROIDS; THYROGLOBULIN; THYROID FUNCTION TESTS; THYROIDITIS, AUTOIMMUNE; THYROTROPIN; THYROXINE;

EID: 84887527083     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513485148     Document Type: Article

References (35)

1. Disanto G, Morahan JM, Barnett MH, et al. The evidence for a role of B cells in multiple sclerosis. Neurology. 2012 ; 78: 823-832
2. Orton SM, Herrera BM, Yee IM, et al. Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol. 2006 ; 5: 932-936
3. Cotsapas C, Voight BF, Rossin E, et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet. 2011 ; 7: e1002254
4. Broadley S, Deans J, Sawcer S, et al. Autoimmune disease in first-degree relatives of patients with multiple sclerosis. Brain. 2000 ; 123: 1102-1111
5. Somers EC, Thomas SL, Smeeth L, et al. Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder?. Am J Epidemiol. 2009 ; 169: 749-755
6. Monzani F, Caraccio N, Dardano A, et al. Thyroid autoimmunity and dysfunction associated with type I interferon therapy. Clin Exp Med. 2004 ; 3: 199-210
7. Jones J.. IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (campath-1H). J Clin Invest. 2009 ; 119: 2052-2061
8. Coles A, Wing M, Smith S, et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet. 1999 ; 354: 1691-1695
9. Airas L, Jalkanen A, Alanen A, et al. Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis. Neurology. 2010 ; 75: 474-476
10. Gaberšček S, Zaletel K. Thyroid physiology and autoimmunity in pregnancy and after delivery. Expert Rev Clin Immunol. 2011 ; 7: 697-707
11. Stagnaro-Green A. Approach to the patient with postpartum thyroiditis. J Clin Endocrinol Metab. 2012 ; 97: 334-342
12. Abalovich M, Gutierrez S, Alcaraz G, et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002 ; 12: 63-68
13. Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: Implications for population screening. J Med Screen. 2000 ; 7: 127-130
14. Benhadi N, Wiersinga WM, Reitsma JB, et al. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol. 2009 ; 160: 985-991
15. Prummel MF, Wiersinga WM. Thyroid autoimmunity and miscarriage. Eur J Endocrinol. 2004 ; 150: 751-755
16. Casey BM. Subclinical hypothyroidism and pregnancy. Obstet Gynecol Surv. 2006 ; 61: 415-420
17. Haddow J, McClain MR, Palomaki G. Thyroperoxidase and thyroglobulin antibodies in early pregnancy and placental abruption. Obstet Gynecol. 2011 ; 117: 287-292
18. Haddow J, Palomaki G, Allan W, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999 ; 341: 549-555
19. Abbassi-Ghanavati M. Thyroid autoantibodies and pregnancy outcomes. Clin Obstet Gyn. 2011 ; 54: 499-505
20. Jalkanen A, Alanen A, Airas L. Pregnancy outcome in women with multiple sclerosis: Results from a prospective nationwide study in Finland. Mult Scler. 2010 ; 16: 950-955
21. Valko PO, Bassetti CL, Bloch KE, et al. Validation of the fatigue severity scale in a Swiss cohort. Sleep. 2008 ; 31: 1601-1607
22. Hansen P, Brix T, Iachine I, et al. The relative importance of genetic and environmental effects for the early stages of thyroid autoimmunity: A study of healthy Danish twins. Eur J Endocrin. 2006 ; 154: 29-38
23. Jensen E, Hyltoft Petersen P, Blaabjerg O, et al. Establishment of a serum thyroid stimulating hormone (TSH) reference interval in healthy adults. The importance of environmental factors, including thyroid antibodies. Clin Chem Lab Med. 2004 ; 42: 824-832
24. Jensen E, Petersen P, Blaabjerg O, et al. Improved sensitivity of a thyrotropin receptor antibody assay. Clin Chem. 2005 ; 51: 2186-2187
25. Thangaratinam S, Tan A, Knox E, et al. Association between thyroid autoantibodies and miscarriage and preterm birth: Meta-analysis of evidence. BMJ. 2011 ; 9 342: d2616
26. Szmyrka-Kaczmarek M, Pokryszko-Dragan A, Pawlik B, et al. Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis. Lupus. 2012 ; 21: 412-420
27. Garg N, Zivadinov R, Ramanathan M, et al. Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients. J Neuroim. 2007 ; 187: 159-165
28. Poppe K, Velkeniers B, Glinoer D. The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab. 2008 ; 4: 394-405
29. Weetman AP. Immunity, thyroid function and pregnancy: Molecular mechanisms. Nat Rev Endocrin. 2010 ; 6: 311-331
30. Klajnbard A, Szecsi PB, Colov NP, et al. Laboratory reference intervals during pregnancy, delivery and the early postpartum period. Clin Chem Lab Med. 2010 ; 48: 237-248
31. Caraccio N, Dardano A, Manfredonia F, et al. Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-b 1a or 1b therapy: Predictive factors of thyroid disease development and duration. J Clin Endocrin Metab. 2005 ; 90: 4133-4137
32. Polman C, Kappos L, Dahlke F, et al. Interferon beta-1b treatment does not induce autoantibodies. Neurology. 2005 ; 64: 996-1000
33. Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: Recent insights and consequences for antenatal and postnatal care. Endocr Rev. 2001 ; 22: 605-630
34. Atzeni F, Doria A, Ghirardello A, et al. Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: Prevalence and clinical value. Autoimmunity. 2008 ; 41: 111-115
35. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011 ; 21: 1081-1125